Page 4 - Polarityte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Polarityte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Polarityte Today - Breaking & Trending Today

PolarityTE (NASDAQ:PTE) and Jasper Therapeutics (NASDAQ:JSPR) Head-To-Head Analysis

PolarityTE (NASDAQ:PTE – Get Rating) and Jasper Therapeutics (NASDAQ:JSPR – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk. Profitability This table compares PolarityTE and Jasper Therapeutics’ net margins, […] ....

United States , Salt Lake City , Redwood City , Polarityte Inc , Jasper Therapeutics Inc , Contract Services , Jasper Therapeutics Company Profile Get Rating , Polarityte Company Profile Get Rating , Get Rating , Jasper Therapeutics , Jasper Therapeutic , Given Jasper Therapeutic , Regenerative Medicine Products , Therapeutics Company Profile , Nasdaq Pte , Stock Comparison , Stock Analysis ,

Short Interest in PolarityTE, Inc. (NASDAQ:PTE) Increases By 519.4%

PolarityTE, Inc. (NASDAQ:PTE – Get Rating) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 372,900 shares, a growth of 519.4% from the May 15th total of 60,200 shares. Based on an average trading volume of 343,100 shares, the short-interest ratio is presently […] ....

United States , First Republic Investment Management Inc , Polarityte Inc , Hightower Advisors , Contract Services , Renaissance Technologies , De Shaw Co , Bernardo Wealth Planning , Cantor Fitzgerald , Get Rating , Republic Investment Management , Tower Advisors , Wealth Planning , Regenerative Medicine Products , Nasdaq Pte ,

PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules

/PRNewswire/ PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, announced today that it has. ....

New York , United States , Salt Lake City , Prnewswire Polarityte Inc , Company Annual , Polarityte Inc , Drug Administration , Exchange Commission , Hc Wainwright Co , Securities Act , Private Securities Litigation Reform Act , Annual Reports ,

$810,000.00 in Sales Expected for PolarityTE, Inc. (NASDAQ:PTE) This Quarter

Equities research analysts forecast that PolarityTE, Inc. (NASDAQ:PTE – Get Rating) will report $810,000.00 in sales for the current quarter, Zacks reports. Two analysts have issued estimates for PolarityTE’s earnings, with the highest sales estimate coming in at $900,000.00 and the lowest estimate coming in at $730,000.00. PolarityTE reported sales of $2.54 million during the […] ....

United States , Morgan Stanley , Polarityte Inc , Zacks Investment Research , Contract Services , Polarityte Company Profile Get Rating , Marshall Wace , Cantor Fitzgerald , Millennium Management , Get Rating , Investment Research , Regenerative Medicine Products , Nasdaq Pte ,

POLARITYTE, INC. : Other Events (form 8-K)

Item 8.01. Other Events.

Nasdaq Listing Deficiency Resolved

On August 13, 2021, PolarityTE, Inc. received a deficiency
letter from the staff of the Listing Qualifications Department of
the Nasdaq. | June 2, 2022 ....

Polarityte Inc , Listing Qualifications Department The Staff , Qualifications Department , Stock Market , Nasdaq Capital Market , Nasdaq Listing Rule , Bid Price , Minimum Bid Price Requirement , Minimum Bid Price Rule , Minimum Bid Price , Edgar Online , Nc Stock Exchange , Press Release , Epartment Pte Us7310942070 ,